HDAC-IN-28

• Description :

  HDAC-IN-28, a novel HDAC inhibitor, shows potent activities against tumor growth and metastasis

• UNSPSC :

  12352005

• Target :

  HDAC

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage; Epigenetics

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/hdac-in-28.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(CCCCCC(N(CC1=CC=C(C2=CN=CN=C2)S1)C3=CC=C(C=C3)OC)=O)NO

• Molecular Formula :

  C23H26N4O4S

• Molecular Weight :

  454.54

• References & Citations :

  [1]Yang F, et al. Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of Bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis. J Med Chem. 2014 Nov 26;57 (22) :9357-69.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1621154-88-8]